Uapacatogoensis of family Euphorbiaceae ailments including pneumonia, cough, fever, rheumatism, vomitting and epilepsy fraction of the stem bark was extract was studied Lorke's method studied in chloroquine-sensitive in each group were used. Group 1 and 4 were administered with 250, 500, and 1000 mg respectively, while group 5 was administered with 5mg chloroquine/kg body weight. The doses were all administered orally. All doses of the extract produced significant, dose dependent, chemo suppressive activity against the parasite in the suppressive, curative and pro was comparable to the group treated with chloroquine. The extract also prolonged the mean survival time of treated mice compared to the untreated group. The oral median lethal dose (LD of the ethyl acetate fraction in mice study showed that the ethyl acetate fraction of the stem bark is safe and has antiplasmodial activity.
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Malaria is an infectious disease that has continued to bidity in the tropics and subMalaria is transmitted to people through the bites of infected female Anopheles mosquitoes, blood transfusion, organ transplantation, shared use of needles and syringes that are or from a mother to her delivery (WHO, 2015) . There that cause malaria in Plasmodium falciparum, Plasmodium vivax, Plasmodium ovale, Plasmodium malariae and 2012;Tcherniuket al., falciparum is more deadly than that caused by the other species of the malaria Africa,most deaths occur among infants, children, pregnant women, and with HIV/AIDS, as well as non-immune migrants, mobile populations and travellers (WHO, Medicinal plants since time immemorial have been used as a source of medicine (Horeau and Da silva, 1999) . The two main antimalarial drugs in use today were derived from plants that had been used the treatment of malaria and other diseases -quinine from the bark of Cinchona tree and artemisin from (Basco et al., 1994 , Addis et al. et al., 2007 .In Ghana, Mali, Nigeria and Zambia, the first line of treatment for 60% of the children with high fevers, resulting from malaria, is the use of herbal medicines at home (WHO, 2002 increasing resistance of malaria to orthodox antimalarial drugs and adverse effects associated with the drugs is one of the greatest chall malarial control today (Mendis Iwuanyanwua et al., 2012) .
with the high cost and or inacessiblity to effective antimalarial drugsdifficulties has stimulated research into the development of newer and more alternatives from the plant kingdom more affordable.
Uapacatogoensis (Pax) family Euphorbaiceae is tree about 13 m high with a short bole, usually without stilt-roots on dry sites, but may be stilted in damp localities, of savanna regions from Senegal to western Cameroon, and in eastern Cameroon to Central African Republic. Sometimes in Sierra Leone it forms nearly pure stands (Burkhill, 1994 http://dx.doi.org/10.4314/bajopas.v9i1.30
for the treatment of various ailments including pneumonia, cough, fever, rheumatism, vomitting and epilepsy. The ethyl acetate analyzed for antiplasmodial activity in mice. Acute toxicity of the prophylactic effect was mice. Five groups, of six mice l distilled water only; groups 2, 3 fraction of Uapacatogoensis while group 5 was administered with 5mg chloroquine/kg body weight. The doses administered orally. All doses of the extract produced significant, dose dependent, chemo suppressive activity against the parasite in the suppressive, curative and prophylactic tests. This was comparable to the group treated with chloroquine. The extract also prolonged the mean survival time of treated mice compared to the untreated group. The oral median lethal dose (LD₅₀) mg/kg body weight. The results of this study showed that the ethyl acetate fraction of the stem bark is safe and has antiplasmodial Uapacatogoensis quinine from the bark of Cinchona tree and artemisin from Artemisia annua et al., 2001 and Odugbemi , 2007) .In Ghana, Mali, Nigeria and Zambia, the 60% of the children with high fevers, resulting from malaria, is the use of bal medicines at home (WHO, 2002) .The increasing resistance of malaria to orthodox adverse effects associated with is one of the greatest challenges facing Mendiset al., 2001;  This situation coupled the high cost and or inacessiblity to effective difficulties has stimulated research into the development of newer and more effective alternatives from the plant kingdom which could be (Pax) family Euphorbaiceae is is a tree about 13 m high with a short bole, usually roots on dry sites, but may be stilted in vanna regions from Senegal to western Cameroon, and in eastern Cameroon to Central African Republic. Sometimes in Sierra Leone it (Burkhill, 1994) . Ethnobotanical/pharmacological studies revealed that Uapaca togoensishas a wide range of activities. U. togoensis is used for treating female infertility and as a restorative wash against fatigue and for making charcoal (Irvine, 1948) . The plant has been used folkorically for the treatment of various ailments including pneumonia, cough, fever, rheumatism, vomitting and epilepsy (Kone et al., 2007) . Extracts from different parts of the plant have been used in the treatment of skin diseases (Ajibesin, 2012) ,
Compounds from the fruits of Uapaca togoensis, have been isolated and have shown good anti cancer activity against nine drug sensitive and multidrugresistant cancer cell lines (Kuete et al., 2015) . The antifugal and antimicrobial activities of the plant has also been reported (Omachi et al., 2015) .
With this view, the present study was executed to investigate the antiplasmodial activity of the ethyl acetate fraction of stem bark extract of Uapaca togoensis in Plasmodium berghei infected mice in order to provide scientific evidence for its use in the therapeutic management of malaria.
MATERIALS AND METHODS Experimental materials Plant material
The stem bark of Uapaca togoensis were collected in 
METHODS

Preparation of plant extract
The freshly collected stem bark of the plant Uapaca togoensis was air-dried under shade for 2 weeks. The dried stem bark were pulverized and reduced to powder using a mortar and pestle. The powdered stem bark (2 kg) was exhaustively subjected to cold maceration with 70%v/v methanol for 72 hours with intermittent agitation. The extract was filtered with the aid of a filter paper (Whatman No. 3) and the filtrate was concentrated to dryness at room temperature. The crude methanol extract (50g) was further partitioned with 200ml of ethyl acetate. The resultant filtrate was concentrated to dryness and used for the study. This was prepared by determining both the percentage parasitaemia and the erythrocytes count of the donor mouse and diluting them with normal saline in proportion indicated by both determinations (Okonkon et al., 2010) .
The parasite Plasmodium berghei
Acute Toxicity Studies
The oral median lethal dose of the ethyl acetate fraction of Uapaca togoensis (EAFUT) was determined in mice using the method of Lorke (1983) . Animals were fasted overnight prior to administration of the fraction. In the initial phase, three (3) groups each consisting of three mice was treated with the ethyl acetate fraction of the plant at doses of 10, 100 and 1000mg/kg body weight orally and observed for signs of toxicity for 4 hours. After 24 hours, the second phase was initiated. In the second phase four groups each containing one animal was administered with four more specific doses of the fraction in geometrically increasing order (1,200mg/kg, 1,600 mg/kg, 2,900 mg/kg and 5,000mg/kg). The animals were then observed for signs of toxicity and mortality for another 24 hours. The LD 50 value was determined by calculating the geometric mean of the lowest dose that caused death and the highest dose for which the animal survived (0/1 and 1/1) respectively.
Preliminary Phytochemical Screening
Phytochemical analysis of the fraction was conducted using standard qualitative method as described by Trease and Evans (2002) .
Evaluation of Suppressive Activity in Early Infection (4-day test).
The method described by Peters and Robinson (1992) was employed.Plasmodium berghei (chloroquine sensitive strain) was used to infect Swiss albino mice for a 4 day suppressive test. A total of thirty mice were used for this study. Each mouse was given standard intra-peritoneal inoculums of 1.0x10 7 P. berghei parasites with the aid of a 1 ml disposablesyringe. The animals were divided into five groups of six mice each. Different doses of the ethyl acetate fraction (250, 500, 1000 mg/kg/day) were administered orally to the segroups. Chloroquine 5 mg/kg/day was given as positive control and 0.2 ml of distilled water as negative control for four consecutive days (D0 to D3). On the fifth day (D4), thin blood smears were prepared and blood films were fixed with methanol. The blood films were stained with Giemsa, and then microscopically examined with 100-x magnification. The percentage suppression of parasitaemia was calculated for each dose level by comparing the parasitaemia in infected controls with those of treated mice. The slides were examined under the microscope and parasitaemia determined by counting the number of parasitized erythrocytes in four fields.
Average percentage chemo suppression was calculated as = (A-B)/A * 100%
Where A = Average parasitaemia in negative control B = Average parasitaemia in positive groups Evaluation of Curative Activity in Established Infection (Rane's test). The method described by Ryley and Peters (1970) was employed. On the first day (day 0) of the study, thirty mice were inoculated intraperitoneally with 0.2ml standard inoculums containing approximately 1x10 7 Plasmodium berghei erythrocytes. Seventy two hours later (day 3), the mice were randomly divided into five groups containing six mice each of both sexes. Group one was administered 0.2ml of distilled water orally. Groups 2-4 received graded doses of the fraction (250mg/kg, 500mg/kg and 1000mg/kg) while group 5 received 5mg/kg of chloroquine (positive control). The fraction and drugs were administered orally daily for 4 days (day 4 -7). On day seven, each mouse was tail bled and a thin blood film was made on a microscope slide. The films were fixed in absolute methanol, stained with Giemsa and examined microscopically to determine the parasitaemia level. After the seventh day, the animals were fed ad libitum and observed for 29 days (day 0-28). Percentage chemo-suppression relative to the negative control was determined for each dose as previously described. Any death that occurred during this period (day 0-28) was noted and the mean survival time (MST) was calculated (Saiduet al., 2000; Adzu and Salawu, 2009; Alliet al., 2011) .
MST = (Number of days survived)/ (Total number of days) Evaluation of Prophylactic (repository) Activity
The prophylactic activity of the extract was investigated using the method described by Peters (1965) . 30 mice of both sexes were randomly divided into five groups each containing six mice. Group 1 was administered with 0.2ml distilled water, groups 2, 3 and 4 were administered with 250, 500 and 1000 mgfraction /kg body weight orally respectively, while group 5 was administered with 1.2mg pyrimethamine/kg body weight orally daily. Treatment continued daily for three days (D₁-D 3 ) and mice were all infected with the parasite on the fourth day (D 4 ). Thin blood films were prepared from each mouse 72hours (D₇) post treatment and mean parasitaemia in each group determined microscopically. Thin blood films stained with Giemsa stain were prepared from tail blood of each mouse and percentage chemo suppression calculated according to the formula stated previously.
Statistical Analysis
Data were expressed as mean ± standard error of mean (SEM). Statistical analysis was carried out using one way analysis of variance (ANOVA) followed by Dunnett t-test. Results were considered to be significant at p<0.05.
RESULTS Preliminary Phytochemical Screening
The ethyl acetate fraction of the stem bark of Uapaca togoensis comprised of glycosides, phenols, triterpenes, steroids, alkaloids, tannins, carbohydrates, saponins and flavonoids (Table 1) .
Acute Toxicity Studies
The median oral lethal dose of the stem bark extract of Uapacatogoensis in mice was found to be greater than 5000mg/kg body weight. There was a remarkable increase in activity in the mice within the first four hours. Nomortality occurred within the observation period of 48 hours.
Antiplasmodial Activity Effect of Suppressive Activity of the Ethyl Acetate Fraction of the Stem Bark U. togoensis
The administration of the fraction resulted in a significant dose-dependent decrease in parasite counts. The average parasite percentage chemo suppression recorded was 39.1, 53.9 and 72.7% at 250, 500 and 1000 mgextract/kg body weight, respectively, while administration of thestandard reference drug (Chloroquine 5mg/kg body weight) produced 98% chemo suppression (Table 2) .
Schizonticidal Activity of the Ethyl Acetate
Fraction of the Stem Bark of U. togoensis
The administration of the fraction also resulted in significant and dose dependent decrease in parasite counts in the treated groups when compared to the control group (Table 3) . The mean parasite count was 15, 9 and 4, at the doses of 250, 500 and 1000 mg/kg bodyweight, respectively, as compared with the mean parasite count of 23.25 in the negative control group. Chloroquine administration of 5 mg/kg chloroquine reduced the mean parasitedensity to 0.1. The dose of extract administered alsoaffected the survival period of the mice. Mean survival time in the distilled water treated group was 10 days. Mice administered with 250, 500 and 1000 mg extract/kg body weight survived for 28, 25 and 24 days respectively. Chloroquine administered mice had survival of 28days after administration similar to the mice treated with 250mg extract/kg body weight (Table 4) .
Prophylactic Activity of the Ethyl Acetate
Fraction of the Stem Bark of U. togoensis
There was a dose dependent prophylactic activity at the doses employed resulting in a significant reduction in extract treated group when compared to the control. Average percentage chemosupression of 31.4, 58.2 and 73.1% was respectively recorded for the corresponding doses of extract (250, 500 and 1000 mg/kg/day). Percentage chemosupression exerted by the standard drug (pyrimethamine1.2mg/kg/day) was 99.2% (Table 5) . 
DISCUSSION
The in vivo antiplasmodial activity and acute toxicity of the ethyl acetate fraction of Uapacatogoensis stem bark extract was investigated. Acute toxicity studies of the ethyl acetate fraction were carried out to determine the safety of the fraction. The oral median lethal dose (LD₅₀) of the fraction was greater than 5000 mg/kg body weight. This suggests that acute oral administration of the fraction is relatively safe (Lorke, 1983 ). Rodent models have been shown to produce disease features similar to those of human plasmodial infection, when infected with P. berghei (Thomas et al., 1998) . Many studies have employed P. berghei in predicting treatment outcome of suspected antimalarial agents, because of its high sensitivity to chloroquine (Agbedahunsi, 2000; Adzu and Salawu 2009 ). Thus P. berghei infected mice was used in this study. The 4 day suppressive test is a standard test commonly used for antimalarial screening (Peters, 1965) .
The ethyl acetate fraction produced significant dose related chemo suppression in all the treated groups with the highest chemo suppression (73%) observed in the group treated with 1000 mg fraction/kg. The chemo-suppression value of the highest dose of the fraction was much higher than that of the lower doses indicating that the fraction has more suppressive activity at higher doses. The fraction also demonstrated significant dose related reduction in parasite count in both established(curative) and residual (repository) infection, comparable to the effect of chloroquine and pyrimethamine, which in this study were usedas standard control drugs. For the mean survival time, mice administered with the lowest dose of the fraction (250 mg/kg) survived for 28 days comparable to the number of days to the chloroquine treated mice. The mechanism by which the ethyl acetate fraction exerts its antiplasmodial action has not been elucidated; however, antiplasmodial effects of natural plant products have been attributed to some of their active phytochemical components (Sofowora, 1980; Ayoolaet al., 2008) . Some of these phytochemicals such as terpenes and flavonoids have been reported to have antiplasmodial activity (Phillipson and Wright, 1990; Christensen and Kharazmi, 2001; Go,2003) . Preliminary phytochemical screening of the ethyl acetate fraction of Uapacatogoensis stem bark revealed the presence of glycosides, phenols, triterpenes, steroids, alkaloids, tannins, carbohydrates, saponins and flavonoids. The antiplasmodial effect of ethyl acetate fraction of U. togoensismay therefore be due to the presence of one or all of the phytochemical components present. CONCLUSION The findings from the study suggest that the ethyl acetate fraction of Uapacatogoensis possesses antiplasmodial activities, and supports the ethno medical claim of the use of theplant in the management of malaria and fever.
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